Skip to content

A prospective cohort study on the early diagnosis of prostate cancer based on multimodal imaging and molecular markers

A prospective cohort study on the early diagnosis of prostate cancer based on multimodal imaging and molecular markers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111522
Enrollment
Unknown
Registered
2025-11-01
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Non-prostate cancer group (benign prostate conditions or no disease):None
Prostate cancer group (diagnosed with early-stage prostate cancer):None

Sponsors

Zhejiang Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years old, male; 2.Patients who are scheduled to undergo prostate biopsy due to prostate cancer screening (such as elevated PSA, abnormal digital rectal examination or suspicious imaging indications); 3.Complete clinical data were available before the operation, including serum prostate-specific antigen (PSA), free PSA ratio, prostate volume, and DRE examination records; 4.Has undergone multimodal imaging examinations (such as mpMRI, ultrasound elastography, etc.) and has clear image data; 5.Agree to collect samples such as blood and urine for molecular marker detection; 6.Have the ability to sign informed consent and voluntarily participate in this study;

Exclusion criteria

Exclusion criteria: 1.Those who have been clearly diagnosed with advanced or metastatic prostate cancer; 2.Previously received prostate cancer-related treatments (such as endocrine therapy, radiotherapy, surgery, etc.); 3.Patients with severe organ dysfunction, immune diseases or mental disorders, etc., who are not suitable for participating in the study; 4.Those whose imaging data or biological samples cannot be obtained, or whose information is incomplete; 5.Patients who are unwilling or unable to cooperate to complete the research follow-up and data collection.

Design outcomes

Primary

MeasureTime frame
The predictive performance of multimodal joint models;The diagnosis rate of early prostate cancer;

Secondary

MeasureTime frame
Positive biopsy cores and tumor burden;Correlation between imaging features and pathological grading;

Countries

China

Contacts

Public ContactQi Zhang

Zhejiang Provincial People's Hospital

clinic@126.com+86 13858019285

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026